Riverhead Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$818K Sell
31,743
-1,714
-5% -$52.1K 0.03% 542
2019
Q2
$983K Buy
33,457
+9,568
+40% +$276K 0.04% 502
2019
Q1
$817K Sell
23,889
-3,204
-12% -$113K 0.03% 522
2018
Q4
$865K Buy
27,093
+693
+3% +$27K 0.04% 481
2018
Q3
$1.27M Buy
26,400
+5,422
+26% +$222K 0.05% 428
2018
Q2
$650K Buy
20,978
+978
+5% +$22.9K 0.03% 589
2018
Q1
$296K Hold
20,000
0.01% 884
2017
Q4
$310K Buy
+20,000
New +$297K 0.01% 884

Other funds holding STAA

Riverhead Capital Management's STAA Position: Q3 2019 in Review

Riverhead Capital Management reduced its STAAR Surgical (STAA) stake by 5.1% in Q3 2019, selling an estimated $52.1K and leaving 31,743 shares worth $818K. The position accounts for 0.03% of the portfolio, ranked #542.

Riverhead Capital Management first reported a position in STAA in Q4 2017 and has held it in 8 quarters since. The position peaked at $1.27M in Q3 2018. 152 funds tracked by Wall St. Rank hold STAA as of Q3 2019.

  • Riverhead Capital Management held 31,743 shares of STAAR Surgical worth $818K as of Q3 2019.
  • Riverhead Capital Management sold 1,714 STAAR Surgical shares in Q3 2019, an estimated $52.1K.
  • STAAR Surgical made up 0.03% of Riverhead Capital Management's portfolio in Q3 2019, its #542 holding.
  • Riverhead Capital Management first reported a position in STAAR Surgical in Q4 2017 and has held it in 8 quarters since.
  • Riverhead Capital Management's STAAR Surgical position peaked at $1.27M in Q3 2018.
  • 152 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.